Taysha Gene Therapies, Inc.
NASDAQ:TSHA
2.05 (USD) • At close January 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -111.566 | -166.014 | -174.523 | -60.011 | -4.46 |
| Depreciation & Amortization
| 1.371 | 1.172 | 0.492 | 0.009 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 7.905 | 18.043 | 18.184 | 3.354 | 0 |
| Change In Working Capital
| -18.012 | 18.518 | 28.667 | -0.111 | 0.54 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.295 | -7.804 | 14.494 | 1.961 | 0 |
| Other Working Capital
| -15.717 | 26.322 | 14.173 | -2.072 | 0.54 |
| Other Non Cash Items
| 47.284 | 39.891 | 10.138 | 26.03 | 3.92 |
| Operating Cash Flow
| -73.018 | -88.39 | -117.042 | -30.729 | 0.135 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -3.869 | -24.869 | -21.554 | -9.082 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -3.483 | -0.061 | -6.25 | -9 | 0 |
| Investing Cash Flow
| -7.352 | -24.93 | -21.554 | -9.082 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| -3.45 | 0 | 39.957 | 0 | 0 |
| Common Stock Issued
| 140.79 | 53.244 | -0.36 | 165.854 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.947 | -1.147 | -0.874 | 125.21 | 0 |
| Financing Cash Flow
| 136.393 | 52.097 | 39.083 | 291.064 | 0 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 56.023 | -61.223 | -99.513 | 251.253 | 0.135 |
| Cash At End Of Period
| 146.54 | 90.517 | 151.74 | 251.253 | 0.135 |